JP2017516883A5 - - Google Patents

Download PDF

Info

Publication number
JP2017516883A5
JP2017516883A5 JP2016561865A JP2016561865A JP2017516883A5 JP 2017516883 A5 JP2017516883 A5 JP 2017516883A5 JP 2016561865 A JP2016561865 A JP 2016561865A JP 2016561865 A JP2016561865 A JP 2016561865A JP 2017516883 A5 JP2017516883 A5 JP 2017516883A5
Authority
JP
Japan
Prior art keywords
cancer
disease
condition
composition according
therapeutic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016561865A
Other languages
English (en)
Japanese (ja)
Other versions
JP6480467B2 (ja
JP2017516883A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2014/004480 external-priority patent/WO2015155810A1/en
Publication of JP2017516883A publication Critical patent/JP2017516883A/ja
Publication of JP2017516883A5 publication Critical patent/JP2017516883A5/ja
Application granted granted Critical
Publication of JP6480467B2 publication Critical patent/JP6480467B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016561865A 2014-04-07 2014-09-01 疎水性薬物送達のための新規なポリマーベースのヒドロトロープ Expired - Fee Related JP6480467B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461976354P 2014-04-07 2014-04-07
US61/976,354 2014-04-07
PCT/JP2014/004480 WO2015155810A1 (en) 2014-04-07 2014-09-01 Novel polymer-based hydrotropes for hydrophobic drug delivery

Publications (3)

Publication Number Publication Date
JP2017516883A JP2017516883A (ja) 2017-06-22
JP2017516883A5 true JP2017516883A5 (OSRAM) 2017-10-19
JP6480467B2 JP6480467B2 (ja) 2019-03-13

Family

ID=51535486

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016561865A Expired - Fee Related JP6480467B2 (ja) 2014-04-07 2014-09-01 疎水性薬物送達のための新規なポリマーベースのヒドロトロープ

Country Status (10)

Country Link
US (1) US10080737B2 (OSRAM)
EP (1) EP3129425B1 (OSRAM)
JP (1) JP6480467B2 (OSRAM)
KR (1) KR102256453B1 (OSRAM)
CN (1) CN106133024B (OSRAM)
AU (1) AU2014390729B2 (OSRAM)
CA (1) CA2943733C (OSRAM)
RU (1) RU2676680C2 (OSRAM)
TW (1) TWI694838B (OSRAM)
WO (1) WO2015155810A1 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105801847A (zh) * 2016-03-16 2016-07-27 华东师范大学 一种用于抗肿瘤药物递送的助溶高分子载体及制备方法
CN112402617B (zh) * 2020-11-20 2023-06-09 汕头大学 血影紫杉醇及其制备方法与应用

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966773A (en) 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US5811119A (en) 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
ATE154514T1 (de) 1989-09-29 1997-07-15 Jolla Cancer Res Found Inhibierung des transformierenden wachstumsfaktor zur verhinderung der anhäufung extrazellulärer matrix
US20040028682A1 (en) 1989-09-29 2004-02-12 Border Wayne A. Inhibiting transforming growth factor beta to prevent accumulation of extracellular matrix
US5234604A (en) 1991-02-26 1993-08-10 Betz Laboratories, Inc. Water soluble block copolymers and methods of use therof
AU670777B2 (en) 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
JPH08268906A (ja) 1995-03-31 1996-10-15 Sumitomo Pharmaceut Co Ltd 肺線維症予防剤
US6120794A (en) 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells
US5851538A (en) 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
US6183774B1 (en) 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
AU756301B2 (en) 1997-08-20 2003-01-09 Somagenics, Inc. Antisense and antigene therapeutics with improved binding properties and methods for their use
JPH11269076A (ja) 1998-01-22 1999-10-05 Seikagaku Kogyo Co Ltd 抗線維化剤
DE60045890D1 (de) 1999-04-27 2011-06-09 Mitsubishi Tanabe Pharma Corp Arzneimittel zur präventiven oder therapeutische Behandlung von Lebererkrankungen
US20020041898A1 (en) 2000-01-05 2002-04-11 Unger Evan C. Novel targeted delivery systems for bioactive agents
EP1267834A4 (en) 2000-03-29 2003-08-27 Aradigm Corp CATIONIC LIPOSOMES
JP2002047211A (ja) 2000-08-04 2002-02-12 Japan Science & Technology Corp 脂溶性物質と生理活性高分子物質結合体および細胞核内への導入方法
EP1392366A4 (en) 2001-04-13 2005-01-19 Population Council Inc CORE RECEPTOR-MEDIATED INTRODUCTION OF A PNA PROTEIN IN CELL CHERRIES
JP4547696B2 (ja) 2001-06-07 2010-09-22 第一三共株式会社 肝硬変予防・治療剤
JP2002371006A (ja) 2001-06-11 2002-12-26 Mochida Pharmaceut Co Ltd 肺線維症予防および/または進行防止剤
JP2003119138A (ja) 2001-10-09 2003-04-23 Tohoku Techno Arch Co Ltd 間質性肺炎および/または肺線維症の予防治療剤
ES2284959T3 (es) 2001-10-30 2007-11-16 Nektar Therapeutics Al, Corporation Conjugados polimericos solubles en agua de acido retinoico.
KR100990055B1 (ko) 2001-11-21 2010-10-26 사이고 가오루 유전자 발현 억제 방법
JP3803318B2 (ja) 2001-11-21 2006-08-02 株式会社RNAi 遺伝子発現阻害方法
EP1465622A1 (en) 2001-11-26 2004-10-13 Arachnova Therapeutics Ltd. Use of ppar activators for the treatment of pulmonary fibrosis
ATE426414T1 (de) 2002-05-15 2009-04-15 Endocyte Inc Vitamin-mitomycin-konjugate
ATE488530T1 (de) 2002-06-19 2010-12-15 Raven Biotechnologies Inc Internalisierende antikörper spezifisch für das raag10 zelloberflächenziel
FR2843117B1 (fr) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
US20080057030A1 (en) 2002-08-27 2008-03-06 Michael Crager Methods of treating idiopathic pulmonary fibrosis
US20050191302A1 (en) 2002-08-29 2005-09-01 University Of Southampton Treatment for liver disease
EP2517729A3 (en) 2003-01-27 2013-01-02 Endocyte, Inc. Vitamin receptor binding drug delivery conjugates
WO2004090108A2 (en) 2003-04-03 2004-10-21 Alnylam Pharmaceuticals Irna conjugates
FR2855521B1 (fr) * 2003-05-28 2005-08-05 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
WO2005084702A1 (ja) 2004-03-02 2005-09-15 Hokkaido Technology Licensing Office Co., Ltd. 臓器線維症予防・治療剤
JP2009221164A (ja) 2008-03-17 2009-10-01 Nitto Denko Corp 肺線維症処置剤
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
US20130171240A1 (en) 2004-12-22 2013-07-04 Nitto Denko Corporation Drug carrier and drug carrier kit for inhibiting fibrosis
HUE056941T2 (hu) 2004-12-22 2022-04-28 Nitto Denko Corp Gyógyszerhordozó és gyógyszerhordozó kit fibrózis gátlására
DE602006013893D1 (de) * 2005-12-05 2010-06-02 Nitto Denko Corp Polyglutamat-Aminosäure-Konjugate und Verfahren
GB0524987D0 (en) 2005-12-08 2006-01-18 Ge Healthcare Ltd Novel imaging agents for fibrosis
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
JP5342834B2 (ja) 2008-09-05 2013-11-13 日東電工株式会社 骨髄線維症処置剤
US20130210744A1 (en) 2007-03-30 2013-08-15 Nitto Denko Corporation Targeting agent for cancer cell or cancer-associated fibroblast
TWI407971B (zh) 2007-03-30 2013-09-11 Nitto Denko Corp Cancer cells and tumor-related fibroblasts
PT2155255E (pt) 2007-05-09 2013-10-15 Nitto Denko Corp Composições que incluem um composto hidrofóbico e um conjugado de poliaminoácido
WO2009036368A2 (en) 2007-09-14 2009-03-19 Nitto Denko Corporation Drug carriers
CA2732412C (en) 2008-07-30 2014-12-09 Lei Yu Retinoid-targeted drug carriers
CN102196823A (zh) 2008-09-12 2011-09-21 日东电工株式会社 纤维化疾病的成像剂
WO2011072082A2 (en) 2009-12-09 2011-06-16 Nitto Denko Corporation Modulation of hsp47 expression
AU2011266057B2 (en) 2010-06-17 2014-12-04 Nitto Denko Corporation Agent for treating renal fibrosis
JP5950428B2 (ja) 2010-08-05 2016-07-13 日東電工株式会社 線維化組織から正常組織を再生するための組成物
US20160015656A2 (en) 2010-08-05 2016-01-21 Nitto Denko Corporation Composition for regenerating normal tissue from fibrotic tissue
ES2708932T3 (es) 2011-06-21 2019-04-12 Nitto Denko Corp Agente inductor de apoptosis
RU2637372C2 (ru) 2011-11-18 2017-12-04 Нитто Денко Корпорейшн Средство для лечения фиброза кишечника
WO2013154707A1 (en) * 2012-04-12 2013-10-17 Nitto Denko Corporation Co-polymer conjugates

Similar Documents

Publication Publication Date Title
IL280941A (en) Modified double-stranded rna agents
JP2016028092A5 (OSRAM)
JP2016065085A5 (OSRAM)
JP2016535100A5 (OSRAM)
JP2016515522A5 (OSRAM)
JP2015503422A5 (OSRAM)
ZA201608108B (en) Huntington's disease therapeutic compounds
JP2016502162A5 (OSRAM)
JP2016523252A5 (OSRAM)
DK3463269T3 (da) Hånddesinfektionsmiddel
JP2016540026A5 (OSRAM)
JP2015173751A5 (OSRAM)
JP2017531686A5 (OSRAM)
JP2015016294A5 (OSRAM)
JP2016069874A5 (OSRAM)
JP2016011847A5 (OSRAM)
JP2017516883A5 (OSRAM)
JP2015168758A5 (OSRAM)
LT3148588T (lt) N,n-bis-2-merkaptoetilizoftalamidas, skirtas parkinsono ligos gydymui
JP2016034310A5 (OSRAM)
JP2015000697A5 (OSRAM)
TH152083B (th) หน้าตัดโลหะ
TH152025B (th) รถแทร็กเตอร์
UA27523S (uk) Оздоблювальний бордюр «капсула»
CN302490243S (zh) 花洒